UBS Group’s Achieve Life Sciences ACHV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$192K Buy
84,914
+18,822
+28% +$42.5K ﹤0.01% 5507
2025
Q1
$176K Buy
66,092
+13,750
+26% +$36.7K ﹤0.01% 5384
2024
Q4
$184K Buy
52,342
+36,104
+222% +$127K ﹤0.01% 5297
2024
Q3
$77K Buy
16,238
+5,788
+55% +$27.4K ﹤0.01% 5349
2024
Q2
$49.1K Buy
10,450
+10,448
+522,400% +$49.1K ﹤0.01% 5559
2024
Q1
$9 Hold
2
﹤0.01% 7936
2023
Q4
$8 Sell
2
-1,257
-100% -$5.03K ﹤0.01% 7912
2023
Q3
$5.41K Buy
1,259
+1,093
+658% +$4.7K ﹤0.01% 6229
2023
Q2
$862 Sell
166
-560
-77% -$2.91K ﹤0.01% 6993
2023
Q1
$4.94K Buy
+726
New +$4.94K ﹤0.01% 7017
2022
Q3
Sell
-1,077
Closed -$5K 9154
2022
Q2
$5K Buy
+1,077
New +$5K ﹤0.01% 7798
2022
Q1
Sell
-80
Closed -$1K 9100
2021
Q4
$1K Hold
80
﹤0.01% 8810
2021
Q3
$1K Sell
80
-509
-86% -$6.36K ﹤0.01% 7971
2021
Q2
$6K Buy
+589
New +$6K ﹤0.01% 7314
2021
Q1
Sell
-5,064
Closed -$41K 7874
2020
Q4
$41K Buy
5,064
+3,038
+150% +$24.6K ﹤0.01% 5355
2020
Q3
$17K Sell
2,026
-2,571
-56% -$21.6K ﹤0.01% 5560
2020
Q2
$37K Buy
4,597
+667
+17% +$5.37K ﹤0.01% 5273
2020
Q1
$26K Buy
3,930
+3,164
+413% +$20.9K ﹤0.01% 5417
2019
Q4
$8K Buy
766
+603
+370% +$6.3K ﹤0.01% 6300
2019
Q3
$6K Buy
+163
New +$6K ﹤0.01% 6416
2019
Q2
Hold
0
6940
2019
Q1
Sell
-49
Closed -$1K 6837
2018
Q4
$1K Sell
49
-300
-86% -$6.12K ﹤0.01% 6937
2018
Q3
$22K Buy
+349
New +$22K ﹤0.01% 5829
2018
Q2
Sell
-41
Closed -$10K 6996
2018
Q1
$10K Buy
41
+39
+1,950% +$9.51K ﹤0.01% 5958
2017
Q4
$1K Sell
2
-11
-85% -$5.5K ﹤0.01% 6704
2017
Q3
$5K Buy
+13
New +$5K ﹤0.01% 6278
2017
Q2
Sell
-34
Closed -$33K 6657
2017
Q1
$33K Buy
+34
New +$33K ﹤0.01% 4873
2016
Q4
Sell
-39
Closed -$43K 6734
2016
Q3
$43K Buy
39
+34
+680% +$37.5K ﹤0.01% 4764
2016
Q2
$10K Buy
5
+3
+150% +$6K ﹤0.01% 5883
2016
Q1
$3K Sell
2
-6
-75% -$9K ﹤0.01% 6300
2015
Q4
$21K Buy
8
+1
+14% +$2.63K ﹤0.01% 5521
2015
Q3
$35K Buy
7
+6
+600% +$30K ﹤0.01% 4974
2015
Q2
$3K Buy
+1
New +$3K ﹤0.01% 6427
2015
Q1
Sell
-1
Closed -$5K 6635
2014
Q4
$5K Buy
+1
New +$5K ﹤0.01% 6324